tiprankstipranks
Nurix Therapeutics (NRIX)
NASDAQ:NRIX
US Market

Nurix Therapeutics (NRIX) Income Statement

Compare
413 Followers

Nurix Therapeutics Income Statement

Last quarter (Q4 2024), Nurix Therapeutics's total revenue was $13.28M, a decrease of -12.37% from the same quarter last year. In Q4, Nurix Therapeutics's net income was $-58.55M. See Nurix Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 54.55M$ 76.99M$ 38.63M$ 29.75M$ 17.82M
Gross Profit
$ 54.55M$ -112.16M$ 27.82M$ 23.67M$ -48.67M
Operating Expenses
$ 267.58M$ 232.05M$ 222.49M$ 147.64M$ 82.80M
Depreciation and Amortization
$ 0.00$ 13.65M$ 10.81M$ 6.08M$ 2.18M
EBITDA
$ -213.03M$ -141.41M$ -173.06M$ -111.80M$ -62.80M
Operating Income
$ -213.03M$ -155.06M$ -183.87M$ -117.89M$ -64.98M
Other Income/Expenses
$ 19.73M$ 11.12M$ 3.51M$ 823.00K$ 1.21M
Pretax Income
$ -193.30M$ -143.95M$ -180.36M$ -117.06M$ -63.78M
Net Income
$ -193.57M$ -143.95M$ -166.04M$ -117.19M$ -43.24M
Per Share Metrics
Basic EPS
$ -2.88$ -2.65$ -3.42$ -2.73$ -2.76
Diluted EPS
$ -2.88$ -2.65$ -3.42$ -2.73$ -2.76
Weighted Average Shares Outstanding
67.12M 54.34M 48.61M 42.90M 15.67M
Weighted Average Shares Outstanding (Diluted)
67.12M 54.34M 48.61M 42.90M 15.67M
Currency in USD

Nurix Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis